These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 33593304)

  • 1. Evaluating treatment response to neoadjuvant chemoradiotherapy in rectal cancer using various MRI-based radiomics models.
    Li Z; Ma X; Shen F; Lu H; Xia Y; Lu J
    BMC Med Imaging; 2021 Feb; 21(1):30. PubMed ID: 33593304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Cui Y; Yang X; Shi Z; Yang Z; Du X; Zhao Z; Cheng X
    Eur Radiol; 2019 Mar; 29(3):1211-1220. PubMed ID: 30128616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine learning-based response assessment in patients with rectal cancer after neoadjuvant chemoradiotherapy: radiomics analysis for assessing tumor regression grade using T2-weighted magnetic resonance images.
    Lee YD; Kim HG; Seo M; Moon SK; Park SJ; You MW
    Int J Colorectal Dis; 2024 May; 39(1):78. PubMed ID: 38789861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting pathological complete response by comparing MRI-based radiomics pre- and postneoadjuvant radiotherapy for locally advanced rectal cancer.
    Li Y; Liu W; Pei Q; Zhao L; Güngör C; Zhu H; Song X; Li C; Zhou Z; Xu Y; Wang D; Tan F; Yang P; Pei H
    Cancer Med; 2019 Dec; 8(17):7244-7252. PubMed ID: 31642204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI Radiomics Model Predicts Pathologic Complete Response of Rectal Cancer Following Chemoradiotherapy.
    Shin J; Seo N; Baek SE; Son NH; Lim JS; Kim NK; Koom WS; Kim S
    Radiology; 2022 May; 303(2):351-358. PubMed ID: 35133200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External validation and comparison of MR-based radiomics models for predicting pathological complete response in locally advanced rectal cancer: a two-centre, multi-vendor study.
    Wei Q; Chen Z; Tang Y; Chen W; Zhong L; Mao L; Hu S; Wu Y; Deng K; Yang W; Liu X
    Eur Radiol; 2023 Mar; 33(3):1906-1917. PubMed ID: 36355199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI-based delta-radiomics are predictive of pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Wan L; Peng W; Zou S; Ye F; Geng Y; Ouyang H; Zhao X; Zhang H
    Acad Radiol; 2021 Nov; 28 Suppl 1():S95-S104. PubMed ID: 33189550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiomics of MRI for pretreatment prediction of pathologic complete response, tumor regression grade, and neoadjuvant rectal score in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation: an international multicenter study.
    Shaish H; Aukerman A; Vanguri R; Spinelli A; Armenta P; Jambawalikar S; Makkar J; Bentley-Hibbert S; Del Portillo A; Kiran R; Monti L; Bonifacio C; Kirienko M; Gardner KL; Schwartz L; Keller D
    Eur Radiol; 2020 Nov; 30(11):6263-6273. PubMed ID: 32500192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine learning-based multiparametric MRI radiomics for predicting poor responders after neoadjuvant chemoradiotherapy in rectal Cancer patients.
    Wang J; Chen J; Zhou R; Gao Y; Li J
    BMC Cancer; 2022 Apr; 22(1):420. PubMed ID: 35439946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selecting Candidates for Organ-Preserving Strategies After Neoadjuvant Chemoradiotherapy for Rectal Cancer: Development and Validation of a Model Integrating MRI Radiomics and Pathomics.
    Wan L; Sun Z; Peng W; Wang S; Li J; Zhao Q; Wang S; Ouyang H; Zhao X; Zou S; Zhang H
    J Magn Reson Imaging; 2022 Oct; 56(4):1130-1142. PubMed ID: 35142001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiomics of locally advanced rectal cancer: machine learning-based prediction of response to neoadjuvant chemoradiotherapy using pre-treatment sagittal T2-weighted MRI.
    Yardimci AH; Kocak B; Sel I; Bulut H; Bektas CT; Cin M; Dursun N; Bektas H; Mermut O; Yardimci VH; Kilickesmez O
    Jpn J Radiol; 2023 Jan; 41(1):71-82. PubMed ID: 35962933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiomics signature as a new biomarker for preoperative prediction of neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.
    Zhang Z; Jiang X; Zhang R; Yu T; Liu S; Luo Y
    Diagn Interv Radiol; 2021 May; 27(3):308-314. PubMed ID: 34003118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI-based radiomics of rectal cancer: preoperative assessment of the pathological features.
    Ma X; Shen F; Jia Y; Xia Y; Li Q; Lu J
    BMC Med Imaging; 2019 Nov; 19(1):86. PubMed ID: 31747902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endorectal ultrasound radiomics in locally advanced rectal cancer patients: despeckling and radiotherapy response prediction using machine learning.
    Abbaspour S; Abdollahi H; Arabalibeik H; Barahman M; Arefpour AM; Fadavi P; Ay M; Mahdavi SR
    Abdom Radiol (NY); 2022 Nov; 47(11):3645-3659. PubMed ID: 35951085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing a prediction model based on MRI for pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Wan L; Zhang C; Zhao Q; Meng Y; Zou S; Yang Y; Liu Y; Jiang J; Ye F; Ouyang H; Zhao X; Zhang H
    Abdom Radiol (NY); 2019 Sep; 44(9):2978-2987. PubMed ID: 31327039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A prediction model of pathological complete response in patients with locally advanced rectal cancer after PD-1 antibody combined with total neoadjuvant chemoradiotherapy based on MRI radiomics].
    Zhang XY; Zhu HT; Li XT; Li YJ; Li ZW; Wang WH; Wu AW; Sun YS; Zhang L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Mar; 25(3):228-234. PubMed ID: 35340172
    [No Abstract]   [Full Text] [Related]  

  • 17. Radiomics Analysis for Evaluation of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
    Liu Z; Zhang XY; Shi YJ; Wang L; Zhu HT; Tang Z; Wang S; Li XT; Tian J; Sun YS
    Clin Cancer Res; 2017 Dec; 23(23):7253-7262. PubMed ID: 28939744
    [No Abstract]   [Full Text] [Related]  

  • 18. Multimodality radiomics prediction of radiotherapy-induced the early proctitis and cystitis in rectal cancer patients: a machine learning study.
    Abbaspour S; Barahman M; Abdollahi H; Arabalibeik H; Hajainfar G; Babaei M; Iraji H; Barzegartahamtan M; Ay MR; Mahdavi SR
    Biomed Phys Eng Express; 2023 Dec; 10(1):. PubMed ID: 37995359
    [No Abstract]   [Full Text] [Related]  

  • 19. MR-based artificial intelligence model to assess response to therapy in locally advanced rectal cancer.
    Ferrari R; Mancini-Terracciano C; Voena C; Rengo M; Zerunian M; Ciardiello A; Grasso S; Mare' V; Paramatti R; Russomando A; Santacesaria R; Satta A; Solfaroli Camillocci E; Faccini R; Laghi A
    Eur J Radiol; 2019 Sep; 118():1-9. PubMed ID: 31439226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does restaging MRI radiomics analysis improve pathological complete response prediction in rectal cancer patients? A prognostic model development.
    Chiloiro G; Cusumano D; de Franco P; Lenkowicz J; Boldrini L; Carano D; Barbaro B; Corvari B; Dinapoli N; Giraffa M; Meldolesi E; Manfredi R; Valentini V; Gambacorta MA
    Radiol Med; 2022 Jan; 127(1):11-20. PubMed ID: 34725772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.